How to Kill Off an Industry

A moment of insight from blogger Andrew Sullivan, on the effect of euro-style socialism on pharmaceutical innovation. Not a pretty picture…
(Image credit)

Read Full Post »

A Toe in the Blog Water

Fellow blogger Toby Bloomberg over at Diva Marketing writes a review of two pharma companies who are beginning to explore the blogosphere. GSK’s effort is focused on just-released OTC product ALLI; J&J’s blog is more general. Check out Toby’s summary and the links provided.

Read Full Post »

Random Interesting Stuff

I come across a lot of items on the web that aren’t necessarily related at all to pharma-world, but some of it sure can be downright interesting! So here is a potpourri of recent finds:
How many of your favorite comic strips came to be born (from Neatorama, where others of these links were found).
Ever seen [...]

Read Full Post »

The New Transparency

Time was, corporate misdeeds could be pretty effectively covered up. Sure, some scandals would leak out and make headlines, but information could often be contained, insiders constrained, or ignorance feigned.
No more. We’re in a time of new transparency.
It’s getting very difficult to keep the lid on wrongdoing, and I, for one, think that is a [...]

Read Full Post »

Pharma News 6_29

Some robust pipelines: Glaxo Oncology, and J&J.
Cephalon moving more rapidly on oncology candidate Treanda.
Glaxo’s cervical cancer vaccine Cervarix looking good.
Byetta, a diabetes drug from Amylin and Lilly, shows solid results after 3 years of usage.
More good press for Actos, Takeda’s competitor to Avandia.
Cholesterol agents acting against diabetic nerve pain?
Two-pronged approach to treating diabetes – the [...]

Read Full Post »

“Customer-Focused Selling”

Last week, I was sitting in a workshop where the theme was a customer-focused selling program.
Now I’m all for customer focus in every aspect of business. That’s what it’s all about. But something was sticking in my craw as I sat through this session (which had to do with a customer-focused selling methodology in the [...]

Read Full Post »

Drugwonks Needs a Proofreader

I’ve been on a slow boil for months over bloggers who abuse basic rules of grammar and spelling. This morning, a Drugwonks post put me over the edge (Drugwonks, fyi, is a pro-industry blog). Robert Goldberg writes a post taking Peter Rost to task for some revelations about Viracept marketing. Here is an excerpt that [...]

Read Full Post »

Paul Potts videos (all together)

Like many around the world, I have been taken up by the wonderful, unfolding saga of Paul Potts, unassuming mobile phone salesman who suddenly burst on the scene like a supernova of singing ability on Britain’s Got Talent. I have three separate posts on this blog; thought it would be easiest (for pass-along purposes) to [...]

Read Full Post »

Trade Show Branding

I recently had a post published on the Small Business Branding blog, my 10th post on that site thus far.
It is on the theme of Branding at a Trade Show – a theme fresh on my mind, having just returned from a conference with an exhibit hall last week.
All of my posts on the SBB [...]

Read Full Post »

SPBT re-cap

It’s Friday morning, and I had no intention of writing a blog post or putting out a Friday Collection newsletter this week. Usually, at the end of a conference, I am so physically and emotionally drained that I turn into a zombie for a day or so.
Strangely, however, after a few days of the most [...]

Read Full Post »